THE VISION

Paradigm shift in anastomotic technique

We innovate, manufacture and deliver

a new generation of surgical instruments

for colorectal surgery

HISTORY

The start 2006

CarpoNovum is founded by two colorectal surgeons

Anders Grönberg, MD, PhD, engineer, and Prof. Henrik Thorlacius, MD, PhD

Award 2007

CarpoNovum received the award for the most successful company in the Connect Sweden network

Award 2007

CarpoNovum received the national Skapa Development Award

CE 2011

CARP®, predecessor of C-REX®, received CE marking

Developing 2011-2018

C-REX® device family was developed, clinical studies were conducted in Sweden, Denmark and China.

CE 2018

CE mark is warded to the C-REX® portfolio

Scandinavian CCS 2020

A subsidiary of CarpoNovum AB, is formed for surgical education and clinical practice.

ABOUT

BOARD OF DIRECTORS

Thomas Enckell, Attorney-at-law

Chairman of the Board

​

Thomas Enckell, chairman of the board, is a lawyer specialized in corporate and real estate law and transactions. He is a member of the Swedish Bar Association and has more than 20 years of experience in M&A and legal issues related to corporate governance. He acts as legal advisor to funds, private equity players and other private companies. Worked at several major Swedish law firms and is founder of Enckell Law Firm. Thomas is board member in a couple of companies in different business areas. 

Jarl Ulf Jungnelius

Member of the Board

​

Trained as an MD and has previously held leading roles in oncology and clinical development at the pharmaceutical companies Celgene, Takeda, Pfizer, and Eli Lilly. Jarl Jungnelius is currently the CEO of Isofol Medical AB.

Ingrid Atteryd-Heiman

Member of the Board

​

She has been active in the Life Science industry since 2012 with board work, both as chairman and member. She is currently a member of companies with drug development and medical technology development. She has a degree in economics from Lund University and an MBA in international business from Uppsala University.

Anders Grönberg

Member of the Board

​

Engineer, MD Ph.D., and Senior colorectal surgeon. Previously active in Halmstad and Malmö. Founder and CEO of CarpoNovum since 2006. Also, responsible for R&D applying his academic knowledge with a focus on wound healing on the intestine and the development of surgical instruments. Has conducted clinical studies since 2008 in Sweden, Denmark, Germany, and China.

Tommy Hedberg

Member of the Board

​

Senior Advisor in a number of life science companies. Tommy has extensive experience in international marketing and sales, clinical development, and product development in pharmaceuticals and medical technology companies such as Atos Medical, Medscand AB and Janssen Pharma AB. Tommy was the CEO of Atos Medical for 17 years.

Jonas Gulliksson

Member of the Board

​

Member of the Swedish and US Bar Associations, European Patent Attorney. Founder of the patent law firm Ström & Gulliksson and the law firm Advokatfirman Gulliksson. Former president of Licensing Executives Society International with extensive knowledge in business law, technology transfer agreements, and intellectual property prosecution. Jonas has almost 50 years of experience in national and international patent and intellectual property litigation and arbitration.

BOARD OF ADVISORS

Ludvig Arbin

Board of Advisors

​

Former county councilor in the region of Uppsala, responsible for public healthcare. In the past, Mr. Arbin was chancellor of the Swedish National Office for Cystic Fibrosis and has many years of experience as a consultant in the sphere of public decision-making in the Swedish healthcare system.

Roger Henriksson

Board of Advisors

​

Professor and senior oncologist at Norrland's University Hospital. Former leader of the regional Cancer Centrum Stockholm Gotland, and of Stockholms oncological clinic, including "Radiumhemmet" at Karolinska University Hospital. Furthermore, Mr. Henriksson has also been chairman of the expert panel advising Stockholm's medicinal committee.

Christophe Genetay

Board of Advisors

​

M.Sc. Civ Eng. and has 25 years experience in the financial industry, working with listed and non-listed companies. Former head of training at the Swedish Council for small investors. Since 2013 been engaged with Investor Relations across various industries.

Torbjörn Holm

Board of Advisors

​

M.D. and professor of surgery at Karolinska Institutet, with colorectal surgery as specialization. Has brought significant contributions to the development of the multi-disciplinary treatment of colorectal cancer in Sweden.

Gunnar Németh

Board of Advisors

​

M.D. and professor of orthopedic surgery. Led the Karolinska hospital department for orthopedic surgery and acting subject specialist in Region Stockholm. He since worked with strategic development within Capio, before advancing to CEO for Capio S:t Görans hospital in 2007. Just over a year later, he took over as CEO of the Capio Group. And since 2011 he has been senior advisor across a number of companies.

Johan Stein

Board of Advisors

​

Lecturer and researcher at Stockholm School of Economics for 10 years. He gained a doctorate degree in 2011, later named docent and professor. Has been Head of research and portfolio manager at a number of hedge funds and with Nordea Investment Management. Also has experience from Alfred Berg and BNP Paribas.

Q&R

Quality and Regulatory

C-REX® devices are CE-marked in Europe. Regulatory approval has been achieved by complying with Medical Device Directive 93/42/EC as Class IIa devices and CarpoNovum holds a certificate of current version of EN ISO 13485.

Quality policy

All team members of CarpoNovum are committed to improve lives of people undergoing colorectal surgery, by providing high-quality, safe and effective products and services that meet our customers’ needs, with focus on continual improvement, by:
 

• having a close collaboration with leading surgeons and health care professionals

• complying with all applicable regulatory requirements

• continually improving the effectiveness of our Quality Management System

• periodically reviewing the performance of the Quality Management System and our Quality Objectives

• communicating this Quality Policy to all team members, subcontractors and suppliers to assure that it is understood and implemented

​

​